In the same year, former Mylan CEO and chairman Robert Coury earned $98 million. Coury’s salary was technically only $1.6 million but he received a $20 million bonus, $50.8 million in stock awards and $22.7 million listed as "other …
HERTFORDSHIRE, England and PITTSBURGH, Nov. 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it is voluntarily delisting the company's ordinary shares from trading on the Tel Aviv Stock Exchange …
StockMarketWire.com - Indivior has confirmed that its US subsidiary, Indivior Inc, together with Monosol Rx, had entered into a settlement agreement with Mylan Pharmaceuticals, Mylan Technologies and Mylan NV resolving patent …
This week, companies like Allergan AGN, Teva TEVA and Mylan MYL were in the limelight. While Mylan and Teva …
Mylan’s stock price surged after their price increase strategy, going from as low as $14.84 per share in 2007, when it first bought EpiPens, to as high as $49.09 on Monday. Attention given to the rising price of the pens has prompted calls …
* Mylan NV - ‍announced it is voluntarily delisting company’s ordinary shares from trading on tel aviv stock exchange * Mylan NV - ‍ delisting of Mylan’s ordinary shares from tase will become effective in three months, on February 12, 2018 ...